NCT06690996View on ClinicalTrials.gov

A Study of LY4005130 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Healthy

Interventions

DRUG

LY4005130

Administered IV

DRUG

LY4005130

Administered SC

DRUG

Placebo

Administered IV

DRUG

Placebo

Administered SC

Trial Locations (1)

75247

RECRUITING

Fortrea Clinical Research Unit, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY